Viewing Study NCT02013804


Ignite Creation Date: 2025-12-24 @ 9:17 PM
Ignite Modification Date: 2026-03-11 @ 9:03 PM
Study NCT ID: NCT02013804
Status: COMPLETED
Last Update Posted: 2017-10-06
First Post: 2013-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies
Sponsor: MedImmune LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-12-19
Start Date Type: ACTUAL
Primary Completion Date: 2017-05-18
Primary Completion Date Type: ACTUAL
Completion Date: 2017-05-18
Completion Date Type: ACTUAL
First Submit Date: 2013-12-12
First Submit QC Date: None
Study First Post Date: 2013-12-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-10-04
Last Update Post Date: 2017-10-06
Last Update Post Date Type: ACTUAL